Assessment of the effectiveness of vaccination against pseudorabies in finishing pigs.
Whereas the clinical efficacy of vaccination against pseudorabies has been studied extensively, methods to evaluate the influence of vaccination on pseudorabies virus (PRV) transmission have only recently become available. In this study, PRV transmission and growth performance in finishing pigs vaccinated either once or twice were compared. The incidence of PRV infections was significantly (P = 0.039) higher in the group vaccinated once (38%) than in the group vaccinated twice (10%). The reproduction ratio R, which is defined as the average number of new infections caused by 1 infectious individual, was estimated in both groups. This ratio was also significantly (P = 0.025) higher among single vaccinated pigs (R = 3.4) than among pigs that had received double vaccination (R = 1.5). In compartments where serologic evidence of PRV introduction was observed, the mean daily weight gain was significantly (P = 0.029) lower in pigs vaccinated once (698 g/d) than in pigs vaccinated twice (721 g/d). Results of this study document the possibility to objectively evaluate the effect of vaccination on PRV transmission under field conditions. From the results, we concluded that double vaccination is advantageous in populations of finishing pigs at risk for PRV introduction. However, even among pigs vaccinated twice, extensive spread of PRV can occur.
Stegeman
A
A
Animal Health Service of the Southern Netherlands, Boxtel.
Van Nes
A
A
de Jong
M C
MC
Bolder
F W
FW
D000818:Animals; D001835:Body Weight; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D015994:Incidence; D009426:Netherlands / Q000453:epidemiology; D011557:Pseudorabies / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D022421:Pseudorabies Vaccines; D013223:Statistics as Topic; D013552:Swine / Q000254:growth & development; D013553:Swine Diseases / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D014611:Vaccination / Q000662:veterinary*; D014613:Vaccines, Attenuated / Q000008:administration & dosage; D014759:Viral Envelope Proteins / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage
D022421:Pseudorabies Vaccines; D014613:Vaccines, Attenuated; D014759:Viral Envelope Proteins; D014765:Viral Vaccines; C089580:glycoprotein E, Suid herpesvirus 1